Novocure Ltd. Forecast, price target & analysts
Novocure Ltd. Target price 2025 - Analyst rating & recommendation
Novocure Ltd. Classifications & Recommendation:
Novocure Ltd. Price Target
| Target Price | $30.60 |
| Price | $13.75 |
| Potential |
122.55%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Novocure Ltd. 2026 .
The average Novocure Ltd. target price is $30.60.
This is
122.55%
register free of charge
$39.90
190.18%
register free of charge
$14.65
6.51%
register free of charge
|
|
| A rating was issued by 14 analysts: 10 Analysts recommend Novocure Ltd. to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novocure Ltd. stock has an average upside potential 2026 of
122.55%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 605.22 | 645.64 |
| 18.82% | 6.68% | |
| EBITDA Margin | -25.98% | -8.99% |
| 40.36% | 65.40% |
10 Analysts have issued a sales forecast Novocure Ltd. 2025 . The average Novocure Ltd. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Novocure Ltd. EBITDA forecast 2025. The average Novocure Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.56 | -1.61 |
| 20.00% | 3.21% | |
| P/E | negative |
10 Analysts have issued a Novocure Ltd. forecast for earnings per share. The average Novocure Ltd. EPS is
This results in the following potential growth metrics and future valuations:
Current Novocure Ltd. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 25 2025 |
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Jul 08 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 27 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
| Wedbush |
Locked
➜
Locked
|
Locked | Apr 16 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Apr 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 25 2025 |
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Jul 08 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 27 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 23 2025 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Apr 16 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Apr 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 14 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
